Nav: Home

Study pinpoints opportunity for oncologists to improve prognosis communication

January 24, 2017

An accurate prognosis for a patient with incurable cancer can help a family make important end-of-life decisions. However, previous research shows that many (or even most) patients with advanced cancer misunderstand their prognosis. A study published in the Journal of Oncology Practice explored doctor-patient conversations at four major academic medical centers to show that patients and their doctors naturally avoid difficult discussions about a challenging prognosis. The paper also pinpoints an opportunity to create a space for this discussion to take place. After communicating test results, an oncologist who asks, "Would you like to talk about what this means?" prompts patients to consider how much they want to know and gives them permission to explore a serious discussion about life and death.

"It was surprising -- at all four of these medical centers, the conversations that oncologists had with their patients tended to follow the same pattern. They would discuss symptoms, then the oncologist would reveal scan results often followed by an immediate transition to talking about the next steps for treatment. What's often missing is a discussion of what the scan results mean," says Sarguni Singh, MD, oncology hospitalist at the University of Colorado Cancer Center. Singh performed her study during residency at the University of Wisconsin with mentor Toby C. Campbell, MD.

The study analyzed 64 conversations recorded as part of a large, multi-site cancer clinical trial. In these conversations, when the oncologist communicated bad news, an average of 50 percent of the conversation was occupied by talk about treatment options. Only 10 percent of all conversations were about scan results. And in these 64 conversations, there were only four instances in which oncologists directly discussed prognosis with their patients.

"The oncologist doesn't want to give a negative view and the patient doesn't want to hear it. They collude to avoid this elephant in the room," Singh says, pointing out that in no way is this collusion intentional. Rather, avoiding the topic of patient's poor prognosis is a cultural norm that, unless consciously countered, can steer doctor-patient communication away from end-of-life topics.

Singh points out that often family members or caregivers are present with a patient and that while it has been shown that patients may misinterpret even frank discussions of prognosis, "the caregivers are processing it too, and maybe in a more intellectual way than the patient," Singh says.

Appreciating a difficult prognosis could allow patients to avoid treatments destined to result in little gain, high cost, and significant side effects.

"Most importantly, these prognosis conversations aren't happening. If it does, it happens very quickly. And patients aren't processing the news," Singh says.

By pausing to ask if a patient wants to talk about what the test results mean, an oncologist can create the opportunity for a patient and his or her family to give their permission to look beyond the "can-do" next steps of treatment to a more holistic understanding of their situation. Dr. Singh and her colleagues think this simple question could open up a dialogue between patients and their oncologists that currently does not exist.
-end-


University of Colorado Anschutz Medical Campus

Related Oncologists Articles:

Oncologists respond swiftly to FDA safety alerts, Penn study finds
Within six months of the U.S. Food and Drug Administration's (FDA) move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
Oncologists echo findings that suggest a reduced risk of breast cancer recurrence
Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast cancer.
ASCO: Oncologists see benefit of medical marijuana, but not comfortable prescribing
73 percent of oncology providers believe that medical marijuana provides benefits for cancer patients, but only 46 percent are comfortable recommending it.
Survey questions cancer doctors' awareness of LGBTQ issues
Most oncologists say they don't know enough about how to treat patients with differences in sexual orientation or identity, but most are also interested in learning more, a new study finds.
Moffitt leads the nation in addressing LGBTQ health care disparities and education
Moffitt launched the first nationwide survey to identify potential gaps in attitudes, knowledge and institutional practices for LGBTQ patients.
More Oncologists News and Oncologists Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...